We are live on ! Find out more
NEOS

Neos Therapeutics, Inc
NEOS

Delisted

NEOS was delisted on the 19th of March, 2021.

Back to rankings

49 hedge funds and large institutions have $65M invested in Neos Therapeutics, Inc in 2017 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 29 increasing their positions, 8 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

263% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 8

114% more capital invested

Capital invested by funds: $30.4M → $65M (+$34.6M)

20% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 5

6% less funds holding

Funds holding: 52 → 49 (-3)

Holders
49
Holders Change
-3
Holders Change %
-5.77%
% of All Funds
1.22%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
6
Increased
29
Reduced
8
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
+$11.6M
2
BlackRock
BlackRock
New York
+$5.57M
3
Franklin Resources
Franklin Resources
California
+$5.34M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$2.49M
5
DA
DSC Advisors
Illinois
+$2.17M

Top Sellers

Rank Fund Capital Flow
1
Northern Trust
Northern Trust
Illinois
-$1.95M
2
PI
Putnam Investments
Massachusetts
-$679K
3
BAMCO Inc
BAMCO Inc
New York
-$412K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$145K
5
Morgan Stanley
Morgan Stanley
New York
-$102K
Name Holding Trade Value Shares
Change 		Change in
Stake
Franklin Resources
1
Franklin Resources
California
$15.7M +$5.34M +860,600 +65%
DM
2
Deerfield Management
New York
$15.1M +$11.6M +1,870,000 +816%
DA
3
DSC Advisors
Illinois
$7.51M +$2.17M +350,188 +50%
BlackRock
4
BlackRock
New York
$6.46M +$5.57M +897,241 +185,764%
Vanguard Group
5
Vanguard Group
Pennsylvania
$4.24M +$2.49M +402,058 +215%
Millennium Management
6
Millennium Management
New York
$3.97M +$1.58M +254,693 +86%
State Street
7
State Street
Massachusetts
$1.76M +$559K +90,099 +58%
Northern Trust
8
Northern Trust
Illinois
$1.2M -$1.95M -313,615 -65%
UBS Group
9
UBS Group
Switzerland
$783K +$38.9K +6,276 +6%
CCI
10
Columbus Circle Investors
$767K +$398K +64,216 +152%
Russell Investments Group
11
Russell Investments Group
United Kingdom
$725K +$83.9K +13,527 +16%
DCM
12
DAFNA Capital Management
California
$686K +$350K +56,400 +145%
Geode Capital Management
13
Geode Capital Management
Massachusetts
$669K +$99K +15,962 +21%
FPC
14
Falcon Point Capital
California
$636K +$16.7K +2,691 +3%
BCM
15
Bridgeway Capital Management
Texas
$576K – – –
Bank of New York Mellon
16
Bank of New York Mellon
New York
$431K +$100K +16,191 +37%
CAM
17
Cormorant Asset Management
Massachusetts
$364K – – –
HAIM
18
Hunter Associates Investment Management
Pennsylvania
$360K +$310K +50,000 New
Wells Fargo
19
Wells Fargo
California
$346K +$169K +27,174 +130%
TCIM
20
TIAA CREF Investment Management
New York
$322K – – –
California State Teachers Retirement System (CalSTRS)
21
California State Teachers Retirement System (CalSTRS)
California
$264K +$51.5K +8,300 +29%
PCM
22
Prelude Capital Management
New York
$224K +$103K +16,570 +114%
Morgan Stanley
23
Morgan Stanley
New York
$221K -$102K -16,397 -35%
SBIA
24
Sheaff Brock Investment Advisors
Indiana
$216K +$186K +30,000 New
TA
25
Teachers Advisors
New York
$214K +$25.9K +4,167 +16%
1
2 3

NEOS Hedge Fund Activity: Q1 2017 in Review

49 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Neos Therapeutics, Inc (NEOS) for Q1 2017, worth a combined $65M — up 114% from $30.4M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new NEOS positions and 5 closed out — a net gain of 1 holder — while 29 added to existing stakes and 8 trimmed.

The largest buyer was Deerfield Management, adding an estimated $11.6M. The largest seller was Northern Trust, cutting an estimated $1.95M.

  • 49 institutional investors held Neos Therapeutics, Inc (NEOS) as of Q1 2017, down from 52 in Q4 2016.
  • Funds reported $65M of Neos Therapeutics, Inc stock for Q1 2017, up 114% quarter-over-quarter.
  • 6 funds opened new Neos Therapeutics, Inc positions in Q1 2017 and 5 closed out, a net change of +1 holder.
  • The largest Neos Therapeutics, Inc buyer in Q1 2017 was Deerfield Management, an estimated $11.6M added.
  • The largest Neos Therapeutics, Inc seller in Q1 2017 was Northern Trust, an estimated $1.95M sold.

Based on aggregated 13F filings for Q1 2017.